NM_024301.5(FKRP):c.946C>A (p.Pro316Thr) AND Muscular dystrophy-dystroglycanopathy type B5
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Mar 25, 2003
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000004445.4
Allele description [Variation Report for NM_024301.5(FKRP):c.946C>A (p.Pro316Thr)]
NM_024301.5(FKRP):c.946C>A (p.Pro316Thr)
Condition(s)
- Name:
- Muscular dystrophy-dystroglycanopathy type B5 (MDDGB5)
- Synonyms:
- MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5; MUSCULAR DYSTROPHY, CONGENITAL, 1C; MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED
- Identifiers:
- MONDO: MONDO:0011688; MedGen: C1847759; OMIM: 606612
-
minimaoside A [Supplementary Concept]
minimaoside A [Supplementary Concept]from Centipeda minima; structure in first source<br/>Date introduced: March 17, 2010<br/>MeSH
-
Pseudodidymella minima [Supplementary Concept]
Pseudodidymella minima [Supplementary Concept]Date introduced: October 1, 2020<br/>MeSH
-
Phaeoacremonium minimum [Supplementary Concept]
Phaeoacremonium minimum [Supplementary Concept]Date introduced: October 1, 2020<br/>MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 8, 2024